… patients with hypercholesterolemia. The European Commission (EC) is expected to make a final decision on the Marketing Authorization Application for Praluent in the European Union in September 2015. Investor Relations Conference Call on Pr...
Fwd: FDA Approved a Potent and Pricey Cholesterol lowering drug today
TEXT-001-HOUSE_OVERSIGHT_025888.txt
p.1
View source release ↗